N6-甲基腺苷阅读蛋白YTHDF1促进结直肠癌中ARHGEF2翻译与RhoA信号传导
该研究通过Ythdf1敲除小鼠、多组学分析和脂质纳米颗粒递送siRNA,发现YTHDF1在结直肠癌中高表达并与转移基因特征相关,YTHDF1通过结合ARHGEF2信使RNA的m6A位点增强其翻译,激活RhoA信号,促进肿瘤生长和转移;靶向该轴的siRNA脂质纳米颗粒在体内抑制肿瘤生长和转移。
要点
- YTHDF1在结直肠癌中高表达,与患者肿瘤转移基因特征显著相关。
- YTHDF1通过识别ARHGEF2信使RNA的m6A位点增强其翻译,激活RhoA信号。
- 脂质纳米颗粒递送ARHGEF2 siRNA在体内显著抑制肿瘤生长和转移。
核心结论
- 研究识别出YTHDF1-m6A-ARHGEF2这一新型致癌表观转录组轴,调控结直肠癌发生和转移。
- 递送siRNA的脂质纳米颗粒药物验证了靶向该轴在结直肠癌中的治疗潜力。
研究设计与样本
- 研究使用Ythdf1敲除小鼠在体内确定Ythdf1在结直肠癌肿瘤发生中的作用。
- 研究对结直肠癌进行RNA测序、m6A甲基化RNA免疫沉淀测序、YTHDF1 RNA免疫沉淀测序和蛋白质组学的多组学分析。
- 研究使用脂质纳米颗粒包裹小干扰RNA评估靶向YTHDF1-m6A-ARHGEF2的治疗潜力。
主要发现
- YTHDF1的DNA拷贝数增加是结直肠癌中的常见事件,并导致其过表达。
- YTHDF1高表达与患者肿瘤中的转移基因特征显著相关。
- Ythdf1敲除小鼠在炎症性结直肠癌模型中肿瘤生长受抑。
- YTHDF1促进结直肠癌细胞系和原代类器官的细胞生长以及体内肺和肝转移。
- 整合多组学分析确定RhoA激活因子ARHGEF2为YTHDF1的关键下游靶点;YTHDF1结合ARHGEF2信使RNA的m6A位点,增强ARHGEF2翻译;ARHGEF2异位表达可恢复YTHDF1缺失导致的RhoA信号、细胞生长和转移能力受损。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: N6-methyladenosine (m6A) governs the fate of RNAs through m6A readers. Colorectal cancer (CRC) exhibits aberrant m6A modifications and expression of m6A regulators. However, how m6A readers interpret oncogenic m6A methylome to promote malignant transformation remains to be illustrated. METHODS: YTH N6-methyladenosine RNA binding protein 1 (Ythdf1) knockout mouse was generated to determine the effect of Ythdf1 in CRC tumorigenesis in vivo. Multiomic analysis of RNA-sequencing, m6A methylated RNA immunoprecipitation sequencing, YTHDF1 RNA immunoprecipitation sequencing, and proteomics were performed to unravel targets of YTHDF1 in CRC. The therapeutic potential of targeting YTHDF1-m6A-Rho/Rac guanine nucleotide exchange factor 2 (ARHGEF2) was evaluated using small interfering RNA (siRNA) encapsulated by lipid nanoparticles (LNP). RESULTS: DNA copy number gain of YTHDF1 is a frequent event in CRC and contributes to its overexpression. High expression of YTHDF1 is significantly associated with metastatic gene signature in patient tumors. Ythdf1 knockout in mice dampened tumor growth in an inflammatory CRC model. YTHDF1 promotes cell growth in CRC cell lines and primary organoids and lung and liver metastasis in vivo. Integrative multiomics analysis identified RhoA activator ARHGEF2 as a key downstream target of YTHDF1. YTHDF1 binds to m6A sites of ARHGEF2 messenger RNA, resulting in enhanced translation of ARHGEF2. Ectopic expression of ARHGEF2 restored impaired RhoA signaling, cell growth, and metastatic ability both in vitro and in vivo caused by YTHDF1 loss, verifying that ARHGEF2 is a key target of YTHDF1. Finally, ARHGEF2 siRNA delivered by LNP significantly suppressed tumor growth and metastasis in vivo. CONCLUSIONS: We identify a novel oncogenic epitranscriptome axis of YTHDF1-m6A-ARHGEF2, which regulates CRC tumorigenesis and metastasis. siRNA-delivering LNP drug validated the therapeutic potential of targeting this axis in CRC.
引用
- Wang S, Gao S, Zeng Y, et al. N6-Methyladenosine Reader YTHDF1 Promotes ARHGEF2 Translation and RhoA Signaling in Colorectal Cancer. Gastroenterology. 2021. PMID: 34968454. doi:10.1053/j.gastro.2021.12.269
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。